The positive correlations between DOK2 and immune checkpoint genes, including HAVCR2, PD-L2, and CTLA4 among others, could be potential mechanisms for immune escape and immunotherapy in AML. This evidence concerns the gene PDCD1LG2 and acute myeloid leukemia.